{"id":52934,"date":"2023-01-16T13:02:23","date_gmt":"2023-01-16T12:02:23","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/small-pharma-phase-ii-iii-cro-benchmarking-market-report-2022-researchandmarkets-com\/"},"modified":"2023-01-16T13:02:23","modified_gmt":"2023-01-16T12:02:23","slug":"small-pharma-phase-ii-iii-cro-benchmarking-market-report-2022-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/small-pharma-phase-ii-iii-cro-benchmarking-market-report-2022-researchandmarkets-com\/","title":{"rendered":"Small Pharma Phase II\/III CRO Benchmarking Market Report 2022 &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5697509\/phase-iiiii-cro-benchmarking-small-pharma?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=ht47rp&amp;utm_campaign=1807948+-+Small+Pharma+Phase+II%2FIII+CRO+Benchmarking+Market+Report+2022&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Phase II\/III CRO Benchmarking &#8211; Small Pharma Market (3rd Ed.)&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230116005292\/en\/1686458\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230116005292\/en\/1686458\/21\/logo.jpg\"><\/a><\/p>\n<p>\nUnderstand the small and emerging biopharma landscape. Are the needs, perceptions, and interactions of this segment different compared to the wider audience of Phase II\/III clinical development outsourcers? In a word, yes.\n<\/p>\n<p>\nThe goal, therefore, of this small and emerging biopharma report is two-fold. First, this research will help small and emerging biopharma companies make more informed CRO selection decisions. Second, these findings will help CROs optimize operational and marketing strategies to better accommodate small and emerging biopharma companies.\n<\/p>\n<p>\nAs these companies continue to increase their role in drug development and innovation, the publisher knows the importance of keeping a pulse on this subset.\n<\/p>\n<p>\nOur goal remains the same &#8211; provide quality market research to ensure both sponsors and providers can glean what they need to make the best decisions possible for their clinical development programs and service offerings.\n<\/p>\n<p>\n<strong>What you will learn:<\/strong>\n<\/p>\n<p>\n<strong>Small &amp; Emerging Sponsors:<\/strong>\n<\/p>\n<ul>\n<li>\nLearn how your peers at small and emerging sponsor companies select their CROs, including key CRO attributes they evaluate, prevalence of PPAs, and the use of outside consultants for CRO selection advice\n<\/li>\n<li>\nDiscover how others at small sponsors evaluate CROs in terms of their personal preference and cost perceptions. Read their rationale for assigning CRO satisfaction scores to further understand how they assess their experiences with service providers\n<\/li>\n<\/ul>\n<p>\n<strong>Service Providers:<\/strong>\n<\/p>\n<ul>\n<li>\nRefine your marketing efforts by focusing on what customers say makes an organization stand out to small and emerging biopharma companies\n<\/li>\n<li>\nUncover the factors influencing small and emerging sponsor outsourcing preferences, and which factors are increasing in importance for future outsourcing\n<\/li>\n<\/ul>\n<p>\n<strong>Major Topics:<\/strong>\n<\/p>\n<ul>\n<li>\nService Provider Selection Process\n<\/li>\n<li>\nService Provider Perceptions and Interactions\n<\/li>\n<li>\nStudy Data\n<\/li>\n<li>\nDemographics\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>Copyright and Usage Guidelines<\/strong>\n<\/p>\n<p>\n<strong>How to Use this Report<\/strong>\n<\/p>\n<p>\n<strong>Small &amp; Emerging Biopharma Segment<\/strong>\n<\/p>\n<p>\n<strong>Analysis Note: Outsourcing Requirement<\/strong>\n<\/p>\n<p>\n<strong>Introduction<\/strong>\n<\/p>\n<p>\n<strong>Methodology<\/strong>\n<\/p>\n<p>\n<strong>Demographics<\/strong>\n<\/p>\n<p>\n<strong>Participant Criteria<\/strong>\n<\/p>\n<p>\n<strong>Major Sections<\/strong>\n<\/p>\n<p>\n<strong>Service Provider Selection Process<\/strong>\n<\/p>\n<ul>\n<li>\nPrimary Section Takeaways\n<\/li>\n<li>\nPreferred Provider Agreements\n<\/li>\n<li>\nSelection Drivers: No Preferred Providers\n<\/li>\n<li>\nService Provider Attributes Gaining Importance: No Preferred Providers\n<\/li>\n<li>\nUse of Outside Consultants\n<\/li>\n<\/ul>\n<p>\n<strong>Service Provider Perceptions and Interactions<\/strong>\n<\/p>\n<ul>\n<li>\nPrimary Section Takeaways\n<\/li>\n<li>\nLeadership, Familiarity, and Reported Use\n<\/li>\n<li>\nService Provider Preference\n<\/li>\n<li>\nService Provider Preference among Users\n<\/li>\n<li>\nCost Perceptions\n<\/li>\n<li>\nCost Experience among Users\n<\/li>\n<li>\nSummary Table\n<\/li>\n<li>\nCRO Loyalty\n<\/li>\n<li>\nOverall Satisfaction\n<\/li>\n<li>\nLikelihood to Use Again\n<\/li>\n<li>\nLikelihood to Recommend\n<\/li>\n<\/ul>\n<p>\n<strong>Study Data<\/strong>\n<\/p>\n<ul>\n<li>\nPhase II\/III Leaders, Unprompted\n<\/li>\n<li>\nPhase II\/III Leaders, Prompted\n<\/li>\n<li>\nService Provider Familiarity\n<\/li>\n<li>\nService Provider Familiarity &#8211; Additional Providers\n<\/li>\n<li>\nService Provider Usage\n<\/li>\n<li>\nService Provider Preference\n<\/li>\n<li>\nService Provider Differentiation\n<\/li>\n<li>\nService Provider Cost Perceptions\n<\/li>\n<li>\nUse of Preferred Providers\n<\/li>\n<li>\nSelection Drivers: Selecting among Preferred Providers\n<\/li>\n<li>\nPreferred Provider Attributes Gaining Importance\n<\/li>\n<li>\nSelection Drivers: When Not Using Preferred Providers\n<\/li>\n<li>\nSelection Drivers: No Preferred Providers\n<\/li>\n<li>\nService Provider Attributes Gaining Importance: No Preferred Providers\n<\/li>\n<li>\nUse of Outside Consultants\n<\/li>\n<\/ul>\n<p>\n<strong>Demographics<\/strong>\n<\/p>\n<ul>\n<li>\nCompany Type\n<\/li>\n<li>\nOffice Location\n<\/li>\n<li>\nJob Title\n<\/li>\n<li>\nDecision-making Responsibility\n<\/li>\n<li>\nOutsourcing Involvement by Phase\n<\/li>\n<li>\nInvolvement in Clinical Development\n<\/li>\n<li>\nTherapeutic Areas of Responsibility\n<\/li>\n<li>\nYears of Industry Experience\n<\/li>\n<\/ul>\n<p>\n<strong>About the Publisher<\/strong>\n<\/p>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5697509\/phase-iiiii-cro-benchmarking-small-pharma?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=ht47rp&amp;utm_campaign=1807948+-+Small+Pharma+Phase+II%2FIII+CRO+Benchmarking+Market+Report+2022&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/9wlgea<\/a>\n<\/p>\n<p>\n<strong>About ResearchAndMarkets.com<\/strong>\n<\/p>\n<p>\nResearchAndMarkets.com is the world&#8217;s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;i&#x6c;&#x74;&#111;&#x3a;p&#114;&#x65;&#115;&#x73;&#64;&#114;&#x65;s&#x65;a&#114;&#x63;h&#x61;&#x6e;&#100;&#x6d;a&#114;&#x6b;&#101;&#x74;s&#46;&#x63;&#111;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x70;&#x72;&#101;&#115;s&#64;&#x72;&#x65;&#x73;&#101;ar&#x63;&#x68;&#x61;&#110;&#100;m&#x61;&#x72;&#x6b;&#101;&#116;s&#x2e;&#x63;&#x6f;&#109;<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Phase II\/III CRO Benchmarking &#8211; Small Pharma Market (3rd Ed.)&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. Understand the small and emerging biopharma landscape. Are the needs, perceptions, and interactions of this segment different compared to the wider audience of Phase II\/III clinical development outsourcers? In a word, yes. The goal, therefore, of &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/small-pharma-phase-ii-iii-cro-benchmarking-market-report-2022-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-52934","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Small Pharma Phase II\/III CRO Benchmarking Market Report 2022 - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/small-pharma-phase-ii-iii-cro-benchmarking-market-report-2022-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Small Pharma Phase II\/III CRO Benchmarking Market Report 2022 - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Phase II\/III CRO Benchmarking &#8211; Small Pharma Market (3rd Ed.)&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. Understand the small and emerging biopharma landscape. Are the needs, perceptions, and interactions of this segment different compared to the wider audience of Phase II\/III clinical development outsourcers? In a word, yes. The goal, therefore, of ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/small-pharma-phase-ii-iii-cro-benchmarking-market-report-2022-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-16T12:02:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230116005292\/en\/1686458\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/small-pharma-phase-ii-iii-cro-benchmarking-market-report-2022-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/small-pharma-phase-ii-iii-cro-benchmarking-market-report-2022-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Small Pharma Phase II\\\/III CRO Benchmarking Market Report 2022 &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2023-01-16T12:02:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/small-pharma-phase-ii-iii-cro-benchmarking-market-report-2022-researchandmarkets-com\\\/\"},\"wordCount\":599,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/small-pharma-phase-ii-iii-cro-benchmarking-market-report-2022-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230116005292\\\/en\\\/1686458\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/small-pharma-phase-ii-iii-cro-benchmarking-market-report-2022-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/small-pharma-phase-ii-iii-cro-benchmarking-market-report-2022-researchandmarkets-com\\\/\",\"name\":\"Small Pharma Phase II\\\/III CRO Benchmarking Market Report 2022 - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/small-pharma-phase-ii-iii-cro-benchmarking-market-report-2022-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/small-pharma-phase-ii-iii-cro-benchmarking-market-report-2022-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230116005292\\\/en\\\/1686458\\\/21\\\/logo.jpg\",\"datePublished\":\"2023-01-16T12:02:23+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/small-pharma-phase-ii-iii-cro-benchmarking-market-report-2022-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/small-pharma-phase-ii-iii-cro-benchmarking-market-report-2022-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/small-pharma-phase-ii-iii-cro-benchmarking-market-report-2022-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230116005292\\\/en\\\/1686458\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230116005292\\\/en\\\/1686458\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/small-pharma-phase-ii-iii-cro-benchmarking-market-report-2022-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Small Pharma Phase II\\\/III CRO Benchmarking Market Report 2022 &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Small Pharma Phase II\/III CRO Benchmarking Market Report 2022 - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/small-pharma-phase-ii-iii-cro-benchmarking-market-report-2022-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Small Pharma Phase II\/III CRO Benchmarking Market Report 2022 - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Phase II\/III CRO Benchmarking &#8211; Small Pharma Market (3rd Ed.)&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. Understand the small and emerging biopharma landscape. Are the needs, perceptions, and interactions of this segment different compared to the wider audience of Phase II\/III clinical development outsourcers? In a word, yes. The goal, therefore, of ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/small-pharma-phase-ii-iii-cro-benchmarking-market-report-2022-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2023-01-16T12:02:23+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230116005292\/en\/1686458\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/small-pharma-phase-ii-iii-cro-benchmarking-market-report-2022-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/small-pharma-phase-ii-iii-cro-benchmarking-market-report-2022-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Small Pharma Phase II\/III CRO Benchmarking Market Report 2022 &#8211; ResearchAndMarkets.com","datePublished":"2023-01-16T12:02:23+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/small-pharma-phase-ii-iii-cro-benchmarking-market-report-2022-researchandmarkets-com\/"},"wordCount":599,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/small-pharma-phase-ii-iii-cro-benchmarking-market-report-2022-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230116005292\/en\/1686458\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/small-pharma-phase-ii-iii-cro-benchmarking-market-report-2022-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/small-pharma-phase-ii-iii-cro-benchmarking-market-report-2022-researchandmarkets-com\/","name":"Small Pharma Phase II\/III CRO Benchmarking Market Report 2022 - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/small-pharma-phase-ii-iii-cro-benchmarking-market-report-2022-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/small-pharma-phase-ii-iii-cro-benchmarking-market-report-2022-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230116005292\/en\/1686458\/21\/logo.jpg","datePublished":"2023-01-16T12:02:23+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/small-pharma-phase-ii-iii-cro-benchmarking-market-report-2022-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/small-pharma-phase-ii-iii-cro-benchmarking-market-report-2022-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/small-pharma-phase-ii-iii-cro-benchmarking-market-report-2022-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230116005292\/en\/1686458\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230116005292\/en\/1686458\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/small-pharma-phase-ii-iii-cro-benchmarking-market-report-2022-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Small Pharma Phase II\/III CRO Benchmarking Market Report 2022 &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52934","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=52934"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52934\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=52934"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=52934"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=52934"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}